Value Line - The Most Trusted Name in Investment Research - Stock Quotes

Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page (2014-10-10)Premium Content

Bristol Myers Squibb Co (BMY)

2014-11-26@08:22:08 ET
Repros Therapeutics had the Lowest Relative Performance in the Pharmaceuticals Industry (RPRX, MDCO, TEVA, BMY, AZN) (F70)

2014-11-25@13:12:17 ET
Global Schizophrenia (First and Second Generation) Therapeutics Market 2014-2018: Increase in Generic Competition (MTO)

2014-11-25@11:15:23 ET
Portola, BMS and Pfizer announce encouraging data from Phase III bleeding study (DTM)

2014-11-25@11:00:42 ET
Bristol-Myers Squibb Shares Up 12.6% Since SmarTrend's Buy Recommendation (BMY) (PSM)

2014-11-25@08:54:05 ET
Bristol Myers (BMY) Showing Bullish Technicals (FBM)

2014-11-25@07:10:30 ET
Celgene's PDE4 Inhibitor Otezla Gets Positive CHMP Opinion (ZAX)

2014-11-25@05:15:24 ET
BMS announces encouraging data from Phase IIIb rheumatoid arthritis analyses (DTM)

2014-11-25@00:30:28 ET
Schizophrenia Therapeutics Market 2018 - First-Generation and Second-Generation Antipsychotics Segments Analyzed at ReportsnReports.com (PRW)

2014-11-24@11:26:33 ET
Bristol Myers (BMY) Showing Resistance Near $59.83 (FBM)

2014-11-24@08:59:09 ET
Bristol-Myers Squibb and Five Prime Therapeutics Announce Exclusive Clinical Collaboration to Evaluate the Combination of Investigational Immunotherapies Opdivo (nivolumab) and FPA008 in Six Tumor Types (PMZ)

2014-11-24@08:59:01 ET
Bristol-Myers Squibb and Five Prime Therapeutics Announce Exclusive Clinical Collaboration to Evaluate the Combination of Investigational Immunotherapies Opdivo (nivolumab) and FPA008 in Six Tumor Types (BIZ)

2014-11-21@15:40:57 ET
Shares of Bristol-Myers Squibb Have Risen Above Previous 52-Week High (F71)

2014-11-21@13:30:19 ET
Bristol Myers (BMY) Trading Near $59.04 Resistance Level (FBM)

2014-11-21@13:07:56 ET
JITENDRA TYAGI APPOINTED AS BMS INDIA COUNTRY HEAD (ABW)

2014-11-21@10:52:12 ET
Bristol-Myers Squibb (BMY) Approaches New Upside Target of $59.04 (F79)

2014-11-20@10:01:02 ET
Bristol Myers (BMY) Showing Support Near $58.01 (FBM)

2014-11-19@20:33:05 ET
Rheumatoid Arthritis Therapeutics Clinical Trials Market by Region, Companies, Trial Status, Phase H2 2014 (PRW)

2014-11-19@12:26:10 ET
Bristol Myers (BMY) Showing Resistance Near $59.43 (FBM)

2014-11-19@07:10:31 ET
Inovio-Roche End Deal for Development of Cancer Therapy (ZAX)

2014-11-19@06:20:00 ET
Bristol-Myers to construct new biologics manufacturing facility in Ireland (DTM)